US 7402595
JNK inhibitor
granted A61KA61K31/472A61K31/4725
Quick answer
US patent 7402595 (JNK inhibitor) held by Takeda Pharmaceutical Company Limited expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/472, A61K31/4725, A61K31/5377, A61P